Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Virginia Coleman Drosos, Murali Prahalad

Premium

Assurex Health announced that Virginia Coleman Drosos is the company's new president. Drosos comes to Assurex after 25 years at Procter & Gamble, where she held various positions. Most recently, she was group president for global beauty care at P&G.


Circulating tumor cell diagnostics developer Epic Sciences has appointed Murali Prahalad to be president and CEO.

Prahalad formerly held multiple posts at Life Technologies, and most recently he was VP of corporate strategies at the firm.

Before he joined Life Technologies, he was VP of business development at Sequenom, and he was a consultant for The Advisory Board Company and an analyst at Gemini Consulting in Tokyo.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more